FDA News

Warnex successfully passes FDA inspection of its bioanalytical facilities

(April 21, 2007)--Warnex reported the favourable outcome from an inspection of its facilities performed by the U.S.Food and Drug Administration (FDA) and completed on April 6, 2007.The FDA inspected and reviewed Warnex's bioanalytical laboratories andtheir quality control systems, as well as several client-specific studies,
during the recent audit. Warnex is compliant with FDA regulations and therewere no major observations requiring any corrective action.

"We are pleased to have once again successfully passed an FDA audit. This achievement demonstrates the ongoing quality of our work at all levels of our organization," said Mark Busgang, President and CEO of Warnex.

Share or bookmarklet this web page at: